Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 1, 1997, Pages 32-43

  Grady, Sharon R ^a   Grun, Elizabeth U ^a   Marks, Michael J ^a   Collins, Allan C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE IODIDE; CARBACHOL IODIDE; CYTISINE; DOPAMINE; HEXAMETHONIUM BROMIDE; METHYLCARBACHOL; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG ACTIVATION; DRUG RECEPTOR BINDING; MATHEMATICAL COMPUTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; STRAIN DIFFERENCE; SYNAPTOSOME;

ANIMALS; BUNGAROTOXINS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MICE, INBRED C57BL; NICOTINE; SYNAPTOSOMES;

EID: 0030770235     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. ALKONDON, M. AND ALBUQUERQUE, E. X.: Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. 1. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol. Exp. Ther. 265: 1455-1473, 1993.
2. ALKONDON, M. AND ALBUQUERQUE, E. X.: Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type III currents. J. Pharmacol. Exp. Ther. 274: 771-782, 1995.
3. BARR, J. E., HOLMS, D. B, RYAN, L. M. AND SHARPLESS, S. K.: Techniques for the chronic cannulation of the jugular vein in mice. Pharmacol. Biochem. Behav. 11: 115-118, 1979.
4. CACHELIN, A. B. AND JAGGI, R.: β subunits determine the time course of desensitization in rat α3 neuronal nicotinic acetylcholine receptors. Eur. J. Physiol. 419: 579-582, 1991.
5. CACHELIN A. B. AND RUST, G.: Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 46: 1168-1174, 1994.
6. CACHELIN, A. B. AND RUST, G.: β-Subunits co-determine the sensitivity of rat neuronal nicotinic receptors to antagonists. Eur. J. Physiol. 429: 449-451, 1995.
7. CHANGEUX, J.-P.: Functional architecture and dynamics of the nicotinic acetylcholine receptor: An allosteric ligand-gated ion channel. Fidia Res. Found. Neurosci. Award Lect. 4: 21-168, 1990.
8. 3H]-dopamine release. Br. J. Pharmacol. 117: 595-606, 1996.
9. COLQUHOUN, L., DINELEY, K. AND PATRICK, J.: A hetero-beta neuronal nicotinic acetylcholine receptor expressed in Xenopus oocytes. Soc. Neurosci. Abstr. 19: 1553, 1993.
10. COVERNTON, P. J. O., KOJIMA, H., SIVILOTTI, L. G., GIBB, A. J. AND COLQUHOUN, D.: Comparison of neuronal nicotinic receptors in rat sympathetic neurons with subunit pairs expressed in Xenopus oocytes. J. Physiol. 481: 27-34, 1994.
11. DUVOISIN, R. M., DENERIS, E. S., BOULTER, J., PATRICK, J. AND HEINEMANN, S.: The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: β4. Neuron 3: 487-496, 1989.
12. EL-BIZRI, H. AND CLARKE, P. B. S.: Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br. J. Pharmacol. 111: 406-413, 1994.
13. FLORES, C. M., ROGER, S. W., PABREZA, L. A., WOLFE, B. B. AND KELLAR, K.: A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic treatment. Mol. Pharmacol. 41: 31-37, 1992.
14. ++ sensor for transmitter release at a central synapse. Cell 79: 717-727, 1994.
15. GERZANICH, V., PENG, X., WANG, F., WELLS, G., ANAND, R., FLETCHER, S. AND LINDSTROM, J.: Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48: 774-782, 1995.
16. GOPALAKRISHNAN, M., MONTEGGIA, L. M., ANDERSON, D. J., MOLINARI, E. J. PIATTONI-KAPLAN, M., DONNELLY-ROBERTS, D., ARNERIC, S. P. AND SULLIVAN, J. P.: Stable expression, pharmacological properties, and regulation of the human neuronal nicotinic α4β2 receptor. J. Pharmacol. Exp. Ther. 276: 289-297, 1996.
17. GOTTI, C., HANKE, W., MAURY, K., MORETTI, M., BALLIVET, M. CLEMENTI, F. AND BERTRAND, D.: Pharmacology and biophysical properties of α7 and α7-α8 α-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur. J. Neurosci. 6: 1281-1291, 1994.
18. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59: 848-856, 1992.
19. 3H]dopamine release from mouse striatal synaptosomes. J. Neurochem. 62: 1390-1398, 1994.
20. GREENGARD, P., VALTORTA, F., CZERNIK, A. J. AND BENFENATI, F.: Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259: 780-785, 1993.
21. GROSS, A., BALLIVET, M., RUNGGER, D. AND BERTRAND, D.: Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes: role of the α subunit in agonist sensitivity and desensitization. Eur. J. Physiol. 419: 545-551, 1991.
22. 3H-nicotine binding on bovine adrenal chromaffin cells. J. Neurosci. 8: 1436-1446, 1988.
23. HORCH, H. L. W. AND SARGENT, P. B.: Perisynaptic surface distribution of multiple classes of nicotinic acetylcholine receptors on neurons in the chicken ciliary ganglion. J. Neurosci. 15: 7778-7795, 1995.
24. KAO, L.-S. AND SCHNEIDER, A. S.: Calcium mobilization and catecholamine secretion in adrenal chromaffin cells; a quin-2 fluorescence study. J. Biol. Chem. 261: 4881-4888, 1986.
25. KATZ, B. AND THESLEFF, S.: A study of the "desensitization" produced by acetylcholine at the motor end-plate. J. Physiol. (Lond.) 138: 63-80, 1957.
26. LINDSTROM, J., ANAND, R., PENG, X. AND GERZANICH, V.: Neuronal nicotinic receptor structure and function. In Effects of Nicotine on Biological Systems II, ed. by P. B. S. Clarke, M. Quik, F. Adlkofer and K. Thurau, pp. 45-52, Birkhauser Verlag, Basel, 1995.
27. 3H]nicotine binding to putative high affinity receptor sites in rat brain. Mol. Pharmacol. 31: 392-400, 1987.
28. LIPPIELLO, P. M., BENCHERIF, M. AND PRINCE, R. J.: The role of desensitization in CNS nicotinic receptor function. In Effects of Nicotine on Biological Systems II, ed. by P. B. S. Clarke, M. Quik, F. Adlkofer and K. Thurau, pp. 79-85, Birkhauser Verlag, Basel, 1995.
29. ++-dependent manner. Trends Neurosci. 18: 177-183, 1995.
30. LUETJE, C. W., WADA, K., ROGERS, S., ABRAMSON, S. N., TSUJI, K., HEINEMANN, S. AND PATRICK, J.: Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J. Neurochem. 55: 632-640, 1990.
31. LUETJE, C. W. AND PATRICK, J.: Both α-and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11: 837-845, 1991.
32. LUETJE, C. W., PIATTONI, M. AND PATRICK, J.: Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric α subunits. Mol. Pharmacol. 44: 657-666, 1993.
33. LUKAS, R. J.: Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line. J. Pharmacol. Exp. Ther. 265: 294-302, 1993.
34. MANDELZYS, A., DE KONINCK, P. AND COOPER, E.: Agonist and toxin sensitivities of ACh-evoked currents on neurons expressing multiple nicotinic ACh receptor subunits. J. Neurophysiol. 74: 1212-1221, 1995.
35. MARKS, M. J., PAULY, J. R., GROSS, S. D., DENERIS, E. S., HERMANS-BORGMEYER, I., HEINEMANN, S. F. AND COLLINS, A. C.: Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12: 2765-2784, 1992.
36. MARKS, M. J., GRADY, S. R. AND COLLINS, A. C.: Down-regulation of nicotinic receptor function after chronic nicotine infusion. J. Pharmacol. Exp. Ther. 266: 1268-1276, 1993a.
37. MARKS, M. J., FARNHAM, D. A., GRADY, S. R. AND COLLINS, A. C.: Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 264: 542-552, 1993b.
38. + efflux from mouse thalamic synaptosomes. J. Pharmacol. Exp. Ther. 277: 1383-1396, 1996.
39. MCGEHEE, D. S. AND ROLE, L. W.: Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57: 521-546, 1995.
40. ++ uptake and catecholamine secretion from adrenal chro-maffin cells by taxol and vinblastine. J. Pharmacol. Exp. Ther. 231: 102-109, 1984.
41. MILLER, R. J.: Receptor mediated regulation of calcium channels and neurotransmitter release. FASEB J. 4: 3291-3299, 1990.
42. MULLE, C. AND CHANGEUX, J.-P.: A novel type of nicotinic receptor in the rat central nervous system characterized by patch-clamp techniques. J. Neurosci. 10: 169-175, 1990.
43. MULLE, C., VIDAL, C., BENOIT, P. AND CHANGEUX, J.-P.: Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system. J. Neurosci. 11: 2588-2597, 1991.
44. MULLE, C., CHOQUET, D., KORN, H. AND CHANGEUX, J.-P.: Calcium influx through nicotinic receptor in rat central neurons: Its relevance to cellular regulation. Neuron 8: 135-143, 1992a.
45. MULLE, C., LENA, C. AND CHANGEUX, J.-P.: Potentiation of nicotinic receptor response by external calcium in rat central neurons. Neuron 8: 937-945, 1992b.
46. OCHOA, E. L. M., CHATTOPADHYAY, A. AND MCNAMEE, M. G.: Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effects of modulators. Cell. Mol. Neurobiol. 9: 141-178, 1989.
47. PENG, X., GERZANICH, V., ANAND, R., WHITING, P. J. AND LINDSTROM, J.: Nicotineinduced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46: 523-530, 1994.
48. PETERSEN, D. R., NORRIS, K. J. AND THOMPSON, J. T.: A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice. Drug Metab. Dis. 12: 725-731, 1984.
49. POPOT, J.-L., SUGIYAMA, H. AND CHANGEUX, J.-P.: Studies on the electrogenic action of acetylcholine with Torpedo marmorata electric organ. II. The permeability response of the receptor-rich membrane fragments to cholinergic agonists in vitro. J. Mol. Biol. 106: 469-483, 1976.
50. RAPIER, C., LUNT, G. G. AND WONNACOTT, S.: Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J. Neurochem. 50: 1123-1130, 1988.
51. 3H]dopamine release from striatal synaptosomes: Pharmacological characterization. J. Neurochem. 54: 937-945, 1990.
52. RATHOUZ, M. M. AND BERG, D. K: Synaptic-type acetylcholine receptors raise intracellular calcium levels in neurons by two mechanisms. J. Neurosci. 14: 6935-6945, 1994.
53. 3H]nicotine eliminates low affinity binding. Life Sci. 46: 935-943, 1990.
54. 3H]dopamine release by nicotine in rat nucleus accumbens. J. Neurochem. 49: 1449-1454, 1987.
55. ROWELL, P. P. AND HILLEBRAND, J. A.: Characterization of nicotine-induced desensitization of evoked dopamine release from rat striatal synaptosomes. J. Neurochem. 63: 561-569, 1994.
56. 3H]dopamine from rat striatal synaptosomes. Neurosci. Lett. 189: 171-175, 1995.
57. SACAAN, A. I., DUNLOP, J. L. AND LLOYD, G. K.: Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther. 274: 224-230, 1995.
58. SACAAN, A. I., MENZAGHI, F., DUNLOP, J. K., CORREA, L. D., WHELAN, K. T. AND LLOYD, G. K.: Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats. J. Pharmacol. Exp. Ther. 276: 509-515, 1996.
59. SARGENT, P. B.: The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16: 403-443, 1993.
60. SCHULTZ, D. W. AND ZIGMOND, R. E.: Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum. Neurosci. Lett. 98: 310-316, 1989.
61. 3H]dopamine release from rat striatal synaptosomes. Neuropharmacology 34: 1535-1541, 1995.
62. ++ channel types coexist to regulate synaptosomal neurotransmitter release. Proc. Natl. Acad. Sci. U.S.A. 90: 9518-9522, 1993.
63. VERNALLIS, A. B., CONROY, W. G. AND BERG, D. K.: Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron 10: 451-464, 1993.
64. VERNINO, S., ROGERS, M., RADCLIFFE, K. A. AND DANI, J. A.: Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors. J. Neurosci. 14: 5514-5524, 1994.
65. WHITING, P., SCHOEPFER, R., LINDSTROM, J. AND PRIESTLEY, T.: Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroplasts. Mol. Pharmacol. 40: 463-472, 1991.
66. WONG, E. T., HOLSTAD, S. G., MENNERICK, S. J., HONG, S. E., ZORUMSKI, C. F. AND ISENBERG, K. E.: Pharmacological and physiological properties of a putative ganglionic nicotinic receptor, α3β4, expressed in transfected eucaryotic cells. Mol. Brain Res. 28: 101-109, 1995.
67. WONNACOTT, S., WILKIE, G., SOLIAKOV, L. AND WHITEAKER, P.: Presynaptic nicotinic autoreceptors and heteroreceptors in the CNS. In Effects of Nicotine on Biological Systems II, ed. by P. B. S. Clarke, M. Quik, F. Adlkofer and K. Thurau, pp. 87-94, Birkhauser Verlag, Basel, 1995.